The latest edition of AJNR (Nov-Dec 2010) has two poignant and very important articles in it
see AJNR -- Table of Contents (31, [10])
1st article I recommend is A.C. Mamourian, H. Young, and M.F. Stiefel AJNR Am J Neuroradiol 2010 31: 1787-1790originally published online on July 1 2010, 10.3174/ajnr.A2192 . [Abstract][Full Text][Figures Only][PDF] The cumulative radiation to SAH patient is very high with serial CT scans, diagnostic angiograms (CTA/DSA), coiling, chest radiographs etc. The authors have given a value of upto 1.8 Gy, however in practice, in may instances this is sure to exceed especially if redo interventions, interventions for vasospasm and repeated check angiograms are needed. From 3 Gy onwards, depilation starts, at 2 Gy erythema starts, and out doses are not very from this value. There has to be more better techniques for reducing the dosage during these procedures. However, till the technology is not available, we must be very selective and careful in our usage of x-ray based machines.
2nd article is P. Jun, N.U. Ko, J.D. English, C.F. Dowd, V.V. Halbach, R.T. Higashida, M.T. Lawton, and S.W. Hetts
SAH leads to vasospasm in 25-30% patients, and leads to prolonged morbidity and poor neurological outcome and even death in few. Traditional treatment with Triple H therapy is helpful many a times, however, endovascular treatment is needed sometimes. The authors have discussed in detail this very important component of SAH management.
Another article in this edition also discusses usage of intra arterial verapamil for vasospam treatment.